Randomised trial of first-line bronchial artery embolisation for non-severe haemoptysis of mild abundance.

ABSTRACT:

Background

Whereas first-line bronchial artery embolisation (BAE) is considered standard of care for the management of severe haemoptysis, it is unknown whether this approach is warranted for non-severe haemoptysis.

Research question

To assess the efficacy on bleeding control and the safety of first-line BAE in non-severe haemoptysis of mild abundance.

Study design and methods

This multicentre, randomised controlled open-label trial enrolled adult patients without major comorbid condition and having mild haemoptysis (onset <72 hours, 100-200 mL estimated bleeding amount), related to a systemic arterial mechanism. Patients were randomly assigned (1:1) to BAE associated with medical therapy or to medical therapy alone.

Results

Bleeding recurrence at day 30 after

SUBMITTER: Fartoukh M 

PROVIDER: S-EPMC8183216 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature